Blood cancers

5 points to consider when managing early relapse in MM

Sponsored by Janssen-Cilag Pty Ltd

There are five important points to consider when treating early relapse in patients with multiple myeloma, a conference has heard. Speaking to the H3 conference hosted by Janssen Oncology in Sydney, Professor Andrew Spencer, Head of Malignant Haematology & Stem Cell Transplantation and the Haematology Clinical Research Unit (CRU) at The Alfred Hospital in Melbourne, ...

Already a member?

Login to keep reading.

© 2021 the limbic